Roche says Avastin restriction removed

ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said the European Medicines Agency has removed a restriction on the label that prevented the use of Avastin in some patients whose cancer had spread to their brain.

Roche said the agency made its decision following a review of a number of analyses from clinical trials, as well as a safety database generated through use of Avastin over more than a decade.

Avastin is approved for the treatment of advanced-stage colorectal cancer, breast cancer, lung cancer and renal cell cancer.

Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.